Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18216112rdf:typepubmed:Citationlld:pubmed
pubmed-article:18216112lifeskim:mentionsumls-concept:C1564874lld:lifeskim
pubmed-article:18216112lifeskim:mentionsumls-concept:C0557351lld:lifeskim
pubmed-article:18216112lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:18216112lifeskim:mentionsumls-concept:C0077678lld:lifeskim
pubmed-article:18216112lifeskim:mentionsumls-concept:C1136102lld:lifeskim
pubmed-article:18216112lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:18216112lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:18216112lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:18216112pubmed:issue7lld:pubmed
pubmed-article:18216112pubmed:dateCreated2008-3-12lld:pubmed
pubmed-article:18216112pubmed:abstractTextDegradation of de novo-generated adeno-associated virus type 5 (AAV5) Rep52 and capsid proteins is part of the limited target specificity displayed by adenovirus type 5 E4Orf6-E1B-55k as part of a cullin 5-containing E3 ligase complex. Both Rep and capsid proteins can be found in the ligase complex, and their presence is dependent on interaction between E4Orf6 and elongins B and C. Degradation of AAV5 proteins can be inhibited by a dominant-negative ubiquitin that prevents chain elongation or by small interfering RNA directed against cullin 5.lld:pubmed
pubmed-article:18216112pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:languageenglld:pubmed
pubmed-article:18216112pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:citationSubsetIMlld:pubmed
pubmed-article:18216112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18216112pubmed:statusMEDLINElld:pubmed
pubmed-article:18216112pubmed:monthAprlld:pubmed
pubmed-article:18216112pubmed:issn1098-5514lld:pubmed
pubmed-article:18216112pubmed:authorpubmed-author:PintelDavid...lld:pubmed
pubmed-article:18216112pubmed:authorpubmed-author:NayakRamnathRlld:pubmed
pubmed-article:18216112pubmed:authorpubmed-author:FarrisK...lld:pubmed
pubmed-article:18216112pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18216112pubmed:volume82lld:pubmed
pubmed-article:18216112pubmed:ownerNLMlld:pubmed
pubmed-article:18216112pubmed:authorsCompleteYlld:pubmed
pubmed-article:18216112pubmed:pagination3803-8lld:pubmed
pubmed-article:18216112pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18216112pubmed:meshHeadingpubmed-meshheading:18216112...lld:pubmed
pubmed-article:18216112pubmed:meshHeadingpubmed-meshheading:18216112...lld:pubmed
pubmed-article:18216112pubmed:meshHeadingpubmed-meshheading:18216112...lld:pubmed
pubmed-article:18216112pubmed:meshHeadingpubmed-meshheading:18216112...lld:pubmed
pubmed-article:18216112pubmed:meshHeadingpubmed-meshheading:18216112...lld:pubmed
pubmed-article:18216112pubmed:meshHeadingpubmed-meshheading:18216112...lld:pubmed
pubmed-article:18216112pubmed:year2008lld:pubmed
pubmed-article:18216112pubmed:articleTitleE4Orf6-E1B-55k-dependent degradation of de novo-generated adeno-associated virus type 5 Rep52 and capsid proteins employs a cullin 5-containing E3 ligase complex.lld:pubmed
pubmed-article:18216112pubmed:affiliationDepartment of Molecular Microbiology and Immunology, University of Missouri-Columbia, School of Medicine, Life Sciences Center, Columbia, Missouri 65211, USA.lld:pubmed
pubmed-article:18216112pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18216112pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:8065entrezgene:pubmedpubmed-article:18216112lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18216112lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18216112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18216112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18216112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18216112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18216112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18216112lld:pubmed